MiNK Therapeutics, Inc.
INKT· Nasdaq
INKTMiNK Therapeutics, Inc.
Filed Nov 29, 2021 · 10-Q · 60 days after period end · 0001564590-21-058700
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Net Income | -$14.27M | -$6.04M |
| EPS Diluted | -$0.59 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MiNK Therapeutics, Inc. · CIK 1840229 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 29, 2021 · 60 d after period end
